Search results for "virus"

showing 10 items of 5024 documents

Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine.

2012

Persistent respiratory syncytial virus (RSV) infections have been associated with the exacerbation of chronic inflammatory diseases, including chronic obstructive pulmonary disease (COPD). This virus infects the respiratory epithelium, leading to chronic inflammation, and induces the release of mucins and the loss of cilia activity, two factors that determine mucus clearance and the increase in sputum volume. These alterations involve reactive oxygen species-dependent mechanisms. The antioxidant N-acetylcysteine (NAC) has proven useful in the management of COPD, reducing symptoms, exacerbations, and accelerated lung function decline. NAC inhibits RSV infection and mucin release in human A54…

Viral DiseasesPulmonologyChronic Obstructive Pulmonary Diseaseslcsh:MedicineMucin 5ACVirus ReplicationAcetylcysteinePulmonary Disease Chronic ObstructiveTubulinRespiratory systemlcsh:ScienceCells CulturedMultidisciplinaryInterleukin-13Microscopy VideoCell DifferentiationForkhead Transcription FactorsFree Radical Scavengersrespiratory systemHost-Pathogen InteractionLower Respiratory Tract InfectionsInfectious Diseasesmedicine.anatomical_structureInterleukin 13Medicinemedicine.symptomResearch Articlemedicine.drugDrugs and DevicesInflammationBronchiRespiratory Syncytial Virus InfectionsBiologyMicrobiologyAntiviral AgentsUpper Respiratory Tract InfectionsmedicineHumansCiliaBiologyInflammationRespiratory Syncytial Virus InfectionA549 cellMucinlcsh:RImmunityEpithelial CellsAxonemal DyneinsEpitheliumAcetylcysteineGene Expression RegulationRespiratory Syncytial Virus HumanRespiratory InfectionsImmunologyRespiratory epitheliumlcsh:QPLoS ONE
researchProduct

To defer or not to defer? A German longitudinal multicentric assessment of clinical practice in urology during the COVID-19 pandemic

2020

PLOS ONE 15(9), e0239027 (2020). doi:10.1371/journal.pone.0239027

Viral DiseasesUrologistsMedizinCancer TreatmentGermanMedical ConditionsRobotic Surgical ProceduresGermanySurveys and QuestionnairesPandemicMedicine and Health SciencesResponse rate (survey)MultidisciplinaryProstate CancerQRProstate DiseasesHospitalizationInfectious DiseasesSurgical OncologyOncologylanguageMedicineCoronavirus InfectionsResearch ArticleUrologic DiseasesClinical Oncologymedicine.medical_specialtyScienceHealth PersonnelUrologyPneumonia ViralMEDLINESurgical and Invasive Medical ProceduresRobotic Assisted SurgeryBetacoronavirusmedicineHumansPenile cancerRobotic surgeryBetacoronavirus; COVID-19; Coronavirus Infections; Germany; Health Personnel; Hospitalization; Humans; Internet; Pandemics; Personal Protective Equipment; Pneumonia Viral; Robotic Surgical Procedures; SARS-CoV-2; Surveys and Questionnaires; Urologic Diseases; UrologistsPandemicsPersonal Protective EquipmentPersonal protective equipmentInternetUrologic InfectionsSARS-CoV-2COVID-19 ; Urology ; Surgical and invasive medical procedures ; Urologic infections ; Surgical oncology ; Robotic assisted surgery ; Cancer treatment ; Prostate cancerGenitourinary Infectionsbusiness.industryGeneral surgeryCOVID-19Cancers and NeoplasmsRobotic Surgical ProceduresCovid 19medicine.diseaselanguage.human_languageGenitourinary Tract TumorsClinical MedicinebusinessPLOS ONE
researchProduct

Modification of the immune response against hepatitis B virus by the human immunodeficiency virus.

1989

Hepatitis B virus and the human immunodeficiency virus are similarly transmitted. Individuals with preexisting HIV infection have a higher chance to become HBsAg carriers than do anti-HIV negative persons. Cytotoxic T cells with specificity for HBcAg, that are under the control of HBcAg-specific helper T cells, are responsible for liver injury. There is good evidence that HIV infection lowers inflammatory activity, is associated with milder liver histology, high levels of viral replication and low seroconversion rates. In addition interferon alpha therapy is less effective in anti-HIV positive subjects. The immune response against HBsAg is helper T-cell dependent and vaccination against hep…

Viral Hepatitis VaccinesHBsAgHepatitis B virusImmunologyAlpha interferonmedicine.disease_causeImmune systemRheumatologyHIV SeropositivitymedicineImmunology and AllergyHumansSeroconversionHepatitis ChronicHepatitis B virusImmunity Cellularbusiness.industryvirus diseasesHIVT-Lymphocytes Helper-InducerHepatitis Bmedicine.diseaseVirologyHBcAgImmunologyCarrier StateInterferon Type IbusinessViral loadT-Lymphocytes CytotoxicRheumatology international
researchProduct

Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma

2002

The incidence of hepatocellular carcinoma is increasing in many countries. The estimated number of new cases annually is over 500,000, and the yearly incidence comprises between 2.5 and 7% of patients with liver cirrhosis. The incidence varies between different geographic areas, being higher in developing areas; males are predominantly affected, with a 2:3 male/female ratio. The heterogeneous geographic distribution reflects the epidemiologic impact of the main etiologic factors and environmental risk, which are the hepatitis B (HBV) and hepatitis C (HCV) viruses. The percentage of cases of hepatocellular carcinoma attributable to HBV worldwide is 52.3% and is higher in Asia where the serop…

Viral Hepatitis VaccinesHepatitis B virusmedicine.medical_specialtyAflatoxin B1Carcinoma HepatocellularCirrhosisPopulationHepacivirusmedicine.disease_causeGastroenterologyGeneral Biochemistry Genetics and Molecular BiologyHistory and Philosophy of ScienceRisk FactorsInternal medicinemedicineCarcinomaHumanseducationHepatitis B viruseducation.field_of_studybusiness.industryGeneral NeuroscienceIncidence (epidemiology)Liver NeoplasmsHepatitis CHepatitis BHepatitis Bmedicine.diseaseHepatitis Cdigestive system diseasesAlcoholsHepatocellular carcinomabusinessAnnals of the New York Academy of Sciences
researchProduct

Signal sequences modulate the immunogenic performance of human hepatitis C virus E2 gene

2005

Abstract Envelope protein E2 of human hepatitis C virus (HCV) is an attractive component of a prototype HCV vaccine. Delivered by DNA immunogens, E2 evokes specific immune response of Th1-type, failing to induce either considerable antibody production, or T-helper cell proliferation. We aimed at modulating the immunogenic performance of E2 gene by changing the mode of protein expression in eukaryotic cells. Plasmids were constructed encoding full-length E2 and nonstructural protein 1 (p7) fused to either 13 or 38 C-terminal amino acids (aa) of HCV E1 that contain second hydrophobic segment of E1 stop-transfer signal, or a complete E1 stop-transfer signal with duplicated second hydrophobic s…

Viral Hepatitis VaccinesSignal peptideGenes ViralMolecular Sequence DataImmunologyHeterologousHepacivirusProtein Sorting SignalsBiologyInjections IntramuscularEpitopeMiceViral ProteinsPlasmidViral Envelope ProteinsChlorocebus aethiopsEscherichia coliAnimalsHumansAmino Acid SequenceMolecular BiologyGeneCellular localizationCell Line TransformedMice Inbred BALB CImmunogenicityGenetic VariationCell Transformation ViralMolecular biologyCOS Cellsbiology.proteinAntibodyHeLa CellsPlasmidsMolecular Immunology
researchProduct

Hepatitis B vaccination and interleukin 2 receptor expression in chronic renal failure

1990

Hepatitis B vaccination and interleukin-2 receptor expression in chronic renal failure. Only 50 to 60% of dialysis patients develop anti-HBs antibodies following hepatitis b vaccination. The nonre-sponder state correlates with impaired monocyte function, decreased interleukin-2 (IL-2) production of T cells, and an upregulation of the IL-2 receptor system. In the present study we examined anti-HBs production after hepatitis B vaccination and the in vitro expression of IL-2 receptors in nondialyzed patients with various degrees of chronic renal failure. Forty-four patients with impaired renal function were immunized with 20 µg recombinant hepatitis B vaccine and boostered after one and six mo…

Viral Hepatitis VaccinesT-LymphocytesReceptor expressionmedicine.disease_causechemistry.chemical_compoundmedicineHumansHepatitis B VaccinesProspective StudiesHepatitis B AntibodiesSeroconversionHepatitis B virusVaccines SyntheticCreatininebiologybusiness.industryVaccinationAntibody titerReceptors Interleukin-2Middle AgedHepatitis Bbiology.organism_classificationVaccinationchemistryHepadnaviridaeNephrologyAntibody FormationImmunologybiology.proteinKidney Failure ChronicAntibodybusinessKidney International
researchProduct

Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice

2014

Coxsackievirus B3 (CVB3) is an important cause of acute and chronic viral myocarditis, and dilated cardiomyopathy (DCM). Although vaccination against CVB3 could significantly reduce the incidence of serious or fatal viral myocarditis and various other diseases associated with CVB3 infection, there is currently no vaccine or therapeutic reagent in clinical use. In this study, we contributed towards the development of a CVB3 vaccine by establishing an efficient and scalable ion exchange chromatography-based purification method for CVB3 virus and baculovirus-insect cell-expressed CVB3 virus-like particles (VLPs). This purification system is especially relevant for vaccine development and produ…

Viral MyocarditisvirusesIon chromatographyGenetic VectorsCoxsackievirus InfectionsBiologyAntibodies ViralVirus03 medical and health sciencesMice0302 clinical medicineImmune systemVirus-like particleAntibody SpecificityVirologyGene OrderAnimalscardiovascular diseases030212 general & internal medicineVaccines Virus-Like Particle030304 developmental biologyPharmacology0303 health sciencesImmunity Cellularta1182virus diseasesmusculoskeletal systemChromatography Ion ExchangeVirology3. Good healthEnterovirus B HumanVaccinationDisease Models AnimalImmunizationCoxsackievirus b3cardiovascular systemFemaleImmunizationBaculoviridaeAntiviral Research
researchProduct

Optimization of the detection of bacteriophages induced from Listeria sp.

1997

It is necessary to isolate new phages in order to improve the rate of typeability of Listeria monocytogenes strains. We propose a method which increases the detection of induced phages in the presence of inhibitory substances synthesized or liberated by the cells during phage production. Of the 29 phages isolated, 11 (38%) were detected by the spot-on-the-lawn technique and 18 (62%) were revealed by the soft-agar technique. To increase the rate of phage detection, both techniques appear useful. Listeria cultures were subjected to phage typing procedures utilizing these newly isolated phages and the French International set of phages. It appears that the newly isolated phages are good tools …

Viral Plaque AssayListeriavirusesViral Plaque AssayBiologybiology.organism_classificationmedicine.disease_causeListeria monocytogenesApplied Microbiology and BiotechnologyVirologyVirusMicrobiologyBacteriophageListeria monocytogenesListeriamedicineBacteriophagesTypingBacteriophage TypingBacteriaPhage typingLetters in Applied Microbiology
researchProduct

Purified Membrane-Containing Procapsids of Bacteriophage PRD1 Package the Viral Genome

2009

Icosahedral-tailed double-stranded DNA (dsDNA) bacteriophages and herpesviruses translocate viral DNA into a preformed procapsid in an ATP-driven reaction by a packaging complex that operates at a portal vertex. A similar packaging system operates in the tailless dsDNA phage PRD1 (Tectiviridae family), except that there is an internal membrane vesicle in the procapsid. The unit-length linear dsDNA genome with covalently linked 5'-terminal proteins enters the procapsid through a unique vertex. Two small integral membrane proteins, P20 and P22, provide a conduit for DNA translocation. The packaging machinery also contains the packaging ATPase P9 and the packaging efficiency factor P6. Here we…

Viral Plaque AssayvirusesATPaseViral Plaque AssayGenomeViral Proteins03 medical and health scienceschemistry.chemical_compoundCapsidBacteriophage PRD1Structural BiologyBacteriophage PRD1Molecular BiologyIntegral membrane protein030304 developmental biology0303 health sciencesMicrobial Viabilitybiology030306 microbiologyVirus AssemblyCell MembraneMembrane ProteinsMolecular biologyMembranechemistryDNA Viralbiology.proteinBiophysicsTectiviridaeDNAJournal of Molecular Biology
researchProduct

High pressure treatment and green tea extract synergistically control enteric virus contamination in beverages

2022

Consumers are driving food production toward the use of natural preservatives and minimal processing technologies. Green tea extract (GTE) at low concentration could be combined with high pressure processing (HPP) for reduced treatment times and quality impact on foods in a hurdle concept for synergistic effects on foodborne viral pathogens, specifically human norovirus and hepatitis A virus (HAV). Viral inactivation by HPP (at 300, 400, and 500 MPa for 5 min) combined with 3.3 mg/mL aged-GTE was initially evaluated in buffer (PBS) against murine norovirus (MNV), a culturable human norovirus surrogate, and HAV. Furthermore, human norovirus inactivation was evaluated by the novel human intes…

Viral inactivationHurdle technologyMicrobiologiaHuman norovirusHepatitis A virusEnteric virusHuman intestinal enteroidFood ScienceBiotechnologyFood safetyEcologia
researchProduct